Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.22.2.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities    
Net loss $ (55,313) $ (15,883)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 115 110
Stock-based compensation expense 2,890 2,383
Change in fair value of warrant liabilities (2,527) (17,210)
Net amortization of premium on marketable securities 556 503
Changes in operating assets and liabilities:    
Decrease (increase) in prepaid expenses and other current and non-current assets 6,709 (6,260)
Increase in accounts payable, accrued and other current liabilities 11,564 3,800
Net cash used in operating activities (36,006) (32,557)
Cash flows from investing activities    
Purchases of marketable securities 0 (47,644)
Sales of marketable securities 2,504  
Proceeds from maturities of marketable securities 21,531 31,034
Purchases of property and equipment (19)  
Net cash provided by (used in) investing activities 24,016 (16,610)
Cash flows from financing activities    
Proceeds from issuance of securities   57,500
Payment of financing costs of securities sold   (3,703)
Proceeds from the exercise of warrants   110
Net cash provided by financing activities   53,907
Net (decrease) increase in cash and cash equivalents (11,990) 4,740
Cash and cash equivalents at beginning of period 16,654 15,485
Cash and cash equivalents at end of period $ 4,664 $ 20,225